期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 167, 期 -, 页码 170-188出版社
ELSEVIER
DOI: 10.1016/j.addr.2020.06.030
关键词
Chemotherapeutics; Nanoplatforms-based drug delivery; Biological barriers; Tumor therapy; Tumor microenvironment
资金
- Cockrell Family Chair Foundation
- office of the Dean of the Cockrell School of Engineering of the University of Texas at Austin (UT)
- UT-Portugal Collaborative Research Program
The widespread development of nanocarriers to deliver chemotherapeutics to specific tumor sites has been motivated by the lack of selective targeting during chemotherapy inducing serious side effects and low therapeutic efficacy. The utmost challenge in targeted cancer therapies is the ineffective drug delivery system, in which the drug-loaded nanocarriers are hindered by multiple complex biological barriers that compromise the therapeutic efficacy. Despite considerable progress engineering novel nanoplatforms for the delivery of chemotherapeutics, there has been limited success in a clinical setting. In this review, we identify and analyze design strategies for improved therapeutic efficacy and unique properties of nanoplatforms, including liposomes, polymeric micelles, nanogels, and dendrimers. We provide a comprehensive and integral description of key biological barriers that nanoplatforms are exposed to during their in vivo journey and discuss associated strategies to overcome these barriers based on the latest research and information available in the field. We expect this review to provide constructive information for the rational design of more effective nanoplatforms to advance precision therapies and accelerate their clinical translation. (C) 2020 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据